Stevanato Group And DWK Life Sciences Sign Non-Exclusive Distribution Agreement For EZ-fill Platform Products

Stevanato Group aims to expand distribution of EZ-fill® whose proven advantages have turned its processing technology into an industry standard for Ready-To-Use products. Stevanato Group S.p.A. (NYSE:STVN), a

Stevanato Group aims to expand distribution of EZ-fill® whose proven advantages have turned its processing technology into an industry standard for Ready-To-Use products.

Stevanato Group S.p.A. (NYSE:STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, and DWK Life Sciences, a leading global manufacturer and provider of precision labware as well as primary packaging solutions for Life Science Research, Diagnostics and Pharmaceutical markets, today announced they have entered a non-exclusive agreement for the distribution and sale of the EZ-fill® Ready-to-Use solutions (RTU) by Stevanato Group.

The collaboration will leverage DWK Life Sciences’ experience in supplying a global network of laboratories and biopharma customers to broaden the distribution of Stevanato Group’s RTU EZ-fill® products, including EZ-fill® vials in Nest & Tub (N&T) and trays, and EZ-fill® Cartridges in Nest & Tub.

RTU containment solutions allow pharmaceutical companies to maximize flexibility in aseptic filling using a common filling platform and can be integrated seamlessly into existing pharmaceutical manufacturing filling lines.

“We are pleased to welcome DWK Life Sciences as a distributor of our EZ-fill® platform”, said Andrea Zambon, Corporate Business Development Senior Director of Stevanato Group. “Through DWK Life Sciences’ established, widespread and specialized network, Stevanato Group aims to broaden the reach of our EZ-fill® products into the pharmaceutical ecosystem, from the laboratory to large-scale manufacturing.”

Over the last 12 years, more than 250 lines have been installed using Stevanato Group EZ-fill® packaging technology. Adopted by many of the leading glass primary packaging suppliers worldwide, EZ-fill® platform has become the market’s most established choice for pre-sterilized containers helping to ensure flexible and streamlined processability. Accommodating both small and large batch production, EZ-fill® can improve drug packaging quality, reduce Total Cost of Ownership (TCO), and shorten overall time-to-market.

Michele Mora, Managing Director & Chief Business Officer for DWK Life Sciences, shared: “We are excited to partner with Stevanato Group to promote the EZ-fill® portfolio and bring the leading RTU primary packaging platform to customers in the DWK Life Sciences global network. The introduction of the EZ-fill® platform supports our strategy to expand best-in-class solutions and services from “Discovery to Delivery” that enable our customers to focus on their efforts to develop and commercialize biopharmaceuticals and therapeutics that improve patient lives.”

For more information, visit http://stevanatogroup.com/.

Total
0
Shares
Related Posts